It will be of great interest to study whether the EGFR‐LFD and concurrent EGFR amplification will contribute to the efficacy of EGFR TKIs in glioblastoma as well as the role of the novel EGFR‐LFDs in different cancer types. This evidence concerns the gene EGFR and cancer.